Data presented at this year’s ASCO conference reinforced the importance of patient identification. Dedham Partners Matthew Cunningham and Aaron McKeon-Fish provided an overview of the conference and the Merck + Moderna readouts for PharmaLive. Check out their insights here: https://ow.ly/uOb650SbjQ2
Very insightful Matthew Cunningham thank you for sharing!
Global Pharma Lead | Board Member | Advisor | Non-Profit | Servant Leader
1moNice summary, Matthew Cunningham I couldn’t agree more: it is time to help patients get to the right, targeted therapy.